Breaking News Instant updates and real-time market news.

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

12:51
09/19/17
09/19
12:51
09/19/17
12:51

Portola Pharmaceuticals mentioned positively at Oppenheimer

  • 02

    Feb

PTLA Portola Pharmaceuticals
$56.57

1.62 (2.95%)

08/10/17
FBCO
08/10/17
NO CHANGE
Target $70
FBCO
Neutral
Portola Pharmaceuticals price target raised to $70 from $58 at Credit Suisse
Credit Suisse analyst Vamil Divan raised his price target for Portola Pharmaceuticals to $70 from $58 after the company reported Q2 financial results and provided an update on Bevyxxa and AndexXa. The analyst also notes that the company is working through some manufacturing process modifications for Bevyxxa that could potentially push the U.S. launch of the product to Q1 of 2018, although its base case is still a launch in September-November of 2017. Divan reiterates a Neutral rating on the shares given the current valuation of the stock following the big move it has had both upon Bevyxxa's approval and in the weeks since then.
08/10/17
SBSH
08/10/17
NO CHANGE
Target $78
SBSH
Buy
Portola post-earnings selloff a buying opportunity, says Citi
Citi analyst Yigal Nochomovitz recommends using the post-earning selloff in shares of Portola Pharmaceuticals as a buying opportunity. The FDA on August 17 is expected to announce its decision on acceptance for review of Portola's biologics license application resubmission for AndexXa. If accepted, AndexXa will have an FDA action date of February 2, 2018, the analyst wrote earlier in a research note. His expectation is that AndexXa will launch immediately if approved in Q1 of 2018 and he sees the drug's sales potential is over $1B. Nochomovitz views Portola's fundamentals as solid and believes a takeout thesis remains in play. The analyst has a Buy rating on the shares with a $78 price target. The stock in midday trading is down $3.94 to $56.45.
08/23/17
FBCO
08/23/17
UPGRADE
FBCO
Outperform
Portola Pharmaceuticals upgraded to Outperform from Neutral at Credit Suisse
08/24/17
08/24/17
UPGRADE
Target $70

Outperform
Portola Pharmaceuticals upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Vamil Divan upgraded Portola Pharmaceuticals to Outperform from Neutral, with a $70 price target, saying the shares sold off following Q2 and that he now sees an attractive entry point.

TODAY'S FREE FLY STORIES

NWPX

Northwest Pipe

$21.72

0.1 (0.46%)

16:36
05/21/18
05/21
16:36
05/21/18
16:36
Hot Stocks
Northwest Pipe awarded Southern Water Supply contract »

Northwest Pipe was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$91.30

-0.22 (-0.24%)

16:35
05/21/18
05/21
16:35
05/21/18
16:35
Hot Stocks
FMC Corporation announces executive leadership appointments »

FMC Corporation announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRDM

Iridium

$11.65

0.1 (0.87%)

16:34
05/21/18
05/21
16:34
05/21/18
16:34
Hot Stocks
Iridium to be recognized by IMO as a mobile satellite services provider in GMDSS »

Iridium announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

CERN

Cerner

$60.75

-0.6 (-0.98%)

16:34
05/21/18
05/21
16:34
05/21/18
16:34
Hot Stocks
Cerner electronic health record selected by Columbus Regional Healthcare System »

Columbus Regional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

TPR

Tapestry

$44.98

0.5 (1.12%)

16:33
05/21/18
05/21
16:33
05/21/18
16:33
Hot Stocks
Tapestry announces departure of Stuart Weitzman creative director »

Tapestry announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 26

    Jun

TWOU

2U

$95.50

-0.16 (-0.17%)

16:33
05/21/18
05/21
16:33
05/21/18
16:33
Syndicate
2U announces $300M common stock offering »

2U, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$139.50

4.45 (3.30%)

16:33
05/21/18
05/21
16:33
05/21/18
16:33
Earnings
Nordson sees Q3 EPS $1.47-$1.63, consensus $1.91 »

Sees Q3 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 06

    Jun

NDSN

Nordson

$139.50

4.45 (3.30%)

16:32
05/21/18
05/21
16:32
05/21/18
16:32
Earnings
Nordson reports Q2 adjusted EPS $1.56, consensus $1.43 »

Reports Q2 revenue $554M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 06

    Jun

SMCI

Super Micro Computer

$23.85

0.2 (0.85%)

16:32
05/21/18
05/21
16:32
05/21/18
16:32
Hot Stocks
Super Micro Computer announces listing requirement notice from Nasdaq »

Super Micro Computer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAR

Darling Ingredients

$18.45

0.275 (1.51%)

16:31
05/21/18
05/21
16:31
05/21/18
16:31
Hot Stocks
Darling Ingredients acquires assets of Kruger Commodities »

Darling Ingredients…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$55.48

2.11 (3.95%)

, INTC

Intel

$54.32

0.82 (1.53%)

16:31
05/21/18
05/21
16:31
05/21/18
16:31
Hot Stocks
Micron, Intel announce production, shipment of 4bits/cell 3D NAND tech »

Micron (MU) and Intel…

MU

Micron

$55.48

2.11 (3.95%)

INTC

Intel

$54.32

0.82 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 30

    May

HTLF

Heartland Financial

$55.70

0.55 (1.00%)

16:31
05/21/18
05/21
16:31
05/21/18
16:31
Hot Stocks
Heartland Financial completes FBLB purchase, sees immediate accretion to EPS »

Heartland Financial USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SAIL

SailPoint

$22.43

-0.16 (-0.71%)

16:30
05/21/18
05/21
16:30
05/21/18
16:30
Syndicate
SailPoint announces common stock offering for holders »

SailPoint Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

16:30
05/21/18
05/21
16:30
05/21/18
16:30
Options
Preliminary option volume of 17.0M today »

Preliminary option volume…

FBK

FB Financial

$43.62

0.61 (1.42%)

16:28
05/21/18
05/21
16:28
05/21/18
16:28
Syndicate
FB Financial files to sell 3.2M shares of common stock for holders »

J.P. Morgan and Stephens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 24

    Sep

MS

Morgan Stanley

$54.37

0.45 (0.83%)

, DQ

Daqo New Energy

$65.37

0.515 (0.79%)

16:27
05/21/18
05/21
16:27
05/21/18
16:27
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Daqo New Energy »

Morgan Stanley reports…

MS

Morgan Stanley

$54.37

0.45 (0.83%)

DQ

Daqo New Energy

$65.37

0.515 (0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 22

    Jun

APA

Apache

$44.27

0.36 (0.82%)

16:26
05/21/18
05/21
16:26
05/21/18
16:26
Recommendations
Apache analyst commentary  »

Apache price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGT

International Game

$29.75

-0.655 (-2.15%)

16:25
05/21/18
05/21
16:25
05/21/18
16:25
Hot Stocks
International Game sees FY18 adjusted EBITDA $1.7B-$1.78B »

Sees FY18 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGT

International Game

$29.75

-0.655 (-2.15%)

16:24
05/21/18
05/21
16:24
05/21/18
16:24
Earnings
International Game reports Q1 adjusted EPS 15c, consensus 27c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$56.37

1.33 (2.42%)

16:23
05/21/18
05/21
16:23
05/21/18
16:23
Syndicate
Breaking Syndicate news story on Square »

Square files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 30

    May

SAIL

SailPoint

$22.43

-0.16 (-0.71%)

16:23
05/21/18
05/21
16:23
05/21/18
16:23
Syndicate
Breaking Syndicate news story on SailPoint »

SailPoint files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

RP

RealPage

$59.45

-0.1 (-0.17%)

16:22
05/21/18
05/21
16:22
05/21/18
16:22
Syndicate
Breaking Syndicate news story on RealPage »

RealPage files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

STKS

One Group Hospitality

$2.49

(0.00%)

16:21
05/21/18
05/21
16:21
05/21/18
16:21
Syndicate
Breaking Syndicate news story on One Group Hospitality »

One Group Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWNK

Hostess Brands

$12.85

0.15 (1.18%)

16:20
05/21/18
05/21
16:20
05/21/18
16:20
Initiation
Hostess Brands initiated  »

Hostess Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXFD

Oxford Immunotec

$13.74

0.18 (1.33%)

16:20
05/21/18
05/21
16:20
05/21/18
16:20
Hot Stocks
Oxford Immunotec T-SPOT TB test included in WHO 'first-ever' essential list »

Oxford Immunotec Global …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.